Rising Danger of E-cigarettes in Brazil: Evali and Health Implications

Regulations by 2FIRSTS.ai
Dec.27.2023
Rising Danger of E-cigarettes in Brazil: Evali and Health Implications
The high number of smokers in Campo Grande, Brazil, has raised concerns as experts warn of a new lung disease caused by e-cigarettes.

According to recent reports from Brazilian news outlet Correiodoestado, data collected through telephone surveys (Vigitel 0) for monitoring risk and protective factors reveals a high number of smokers in the city. Among them, 6.9% are male and 8.6% are female.

 

As more and more individuals adopt the use of e-cigarettes, medical experts are issuing warnings about a newly emerging lung illness called Evali, specifically caused by the use of e-cigarettes.

 

Healthcare professionals are engaged in a battle against e-cigarettes, according to respiratory disease expert Henrique Ferreira de Brito, as these devices are deemed more harmful than conventional cigarettes.

 

Although e-cigarette devices, also known as Electronic Smoking Devices (DEF), do not burn tobacco, their nicotine content is higher than that of "regular" cigarettes, resulting in greater and faster dependency.

 

Doctors say that e-cigarettes have a higher dependency, contain higher levels of nicotine, and can reach the human brain faster, resulting in a dependency on nicotine additives. Therefore, in addition to the inherent dangers of nicotine itself, e-cigarettes also contain other substances different from traditional cigarettes that pose serious health risks.

 

The doctor further explained that these substances are associated with various diseases, including heart disease, lung disease, cardiovascular disease, cancer, and Evali.

 

The São Paulo Research Foundation (Fapesp) has published an article revealing a brief history of this new type of lung disease, which was first discovered in the United States in 2009.

 

At the time, many young people in their twenties, some of whom had never suffered from respiratory diseases before, were experiencing symptoms such as difficulty breathing, coughing, and chest pains in American hospitals. Additionally, many individuals also reported abdominal pain, nausea, vomiting, diarrhea, fatigue, fever, and weight loss.

 

According to this historical record, all patients have one common factor: they are all users of e-cigarettes. In Brazil, there have been recorded cases of Evali, some of which also exhibit typical symptoms of viral pneumonia caused by Covid-19.

 

A recent study conducted by the Brazilian Institute of Geography and Statistics (IBGE) revealed that the teenage e-cigarette usage rate in Campo Grande is the highest in Brazil, with 0.9% of ninth-grade students having already tried e-cigarettes.

 

Doctors have warned that the sale, import, distribution, and marketing of e-cigarettes are prohibited under Resolution of the Collegiate Board. Although the use itself is not banned, currently all buying and selling is prohibited. Young people are particularly susceptible to the allure of e-cigarettes and may mistakenly believe they are harmless. However, this is a lie, as e-cigarettes, even those without nicotine, pose significant health risks.

 

Doctors say that factors contributing to the difficulties of quitting smoking include the release of dopamine when nicotine is consumed. Users constantly crave that feeling, which leads to an escalation in both frequency and quantity of smoking. However, in addition to chemical dependence, there are also psychological and physiological dependencies.

 

In order to quit smoking, doctors recommend that besides the individual's determination, they should also have a medical team consisting of a nutritionist, a psychologist, and a pulmonary specialist to accompany them. These professionals will assist in changing habits and utilize medications that aid in improving the chemical dependency sensation.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

South Korea to regulate synthetic-nicotine e-liquids as tobacco from April 24
South Korea to regulate synthetic-nicotine e-liquids as tobacco from April 24
South Korea’s Health Ministry says amendments to the Tobacco Business Act will take effect on April 24, bringing synthetic-nicotine e-liquid vapes under the legal definition of tobacco. The shift extends cigarette-style rules to these products, including mandatory graphic warnings, sharply limited advertising channels, stricter vending-machine placement requirements, and a ban on use in smoke-free areas, with enforcement checks slated from late April.
Feb.03 by 2FIRSTS.ai
Malaysia health minister says court conviction over vape promotion sets key precedent for Act 852 enforcement
Malaysia health minister says court conviction over vape promotion sets key precedent for Act 852 enforcement
Malaysia’s Health Minister Datuk Seri Dr Dzulkefly Ahmad said the Putrajaya Magistrate’s Court decision to convict a known personality for promoting vape has set an important legal precedent for enforcing the Control of Smoking Products for Public Health Act (Act 852).
Jan.09 by 2FIRSTS.ai
Nebraska Lawmakers Consider Major Tax Hikes on Cigarettes, Vapes and Other Nicotine Products
Nebraska Lawmakers Consider Major Tax Hikes on Cigarettes, Vapes and Other Nicotine Products
Nebraska lawmakers are considering two tax bills targeting nicotine products. LB1124 would raise the cigarette tax from $0.64 to $1.64 per pack, while LB1238 would shift cigarettes to a 30% tax on the retailer’s purchase price and increase taxes on alternative nicotine and other tobacco products to 30%. The commentary argues the hikes could raise consumer costs, pressure small retailers, and increase cross-border shopping and illicit market activity.
Feb.04 by 2FIRSTS.ai
The UK government plans to expand the scope of its e-cigarette ban to include playgrounds, off-campus areas, and areas outside hospitals.
The UK government plans to expand the scope of its e-cigarette ban to include playgrounds, off-campus areas, and areas outside hospitals.
Government plans would ban vaping in cars carrying children and restrict smoking, vaping and heated tobacco in settings including playgrounds and outside schools across England, subject to a 12-week public consultation. The proposals also say indoor spaces where smoking is already banned would become vape- and heated-tobacco-free, and areas outside hospitals would be included.
Feb.13 by 2FIRSTS.ai
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
Rethinking Nicotine Harm Reduction: A Neuroscientist’s Perspective on Scientific Gaps and Future Directions — By Dr. Xin-an Liu
After France’s ANSES report on nicotine products and harm reduction, Dr. Xin-an Liu wrote to 2Firsts reassessing the field’s foundations. She argues the debate reveals gaps in evidence on long-term behavioral substitution, addiction pathways and neurobiological impacts, and calls for longitudinal research, integrated behavioral science and neuroimaging, clearer risk assessment and stronger transparency to ensure policy and next-generation product development rest on solid evidence.
Industry Insight
Feb.24
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11